We use cookies to measure traffic and show relevant ads. By clicking Accept you agree to our use of analytics and advertising cookies.
EMA批准CASGEVY用于5-11岁镰状细胞贫血儿童。100%疗效，价格180万欧元。风险与收益——分析中。了解更多。
